NCT01447654View on ClinicalTrials.gov

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Losartan

100 mg for 12 months.

DRUG

Placebo

100 mg for 12 months.

Trial Locations (1)

2100

Department of cardiology, Rigshospitalet., Copenhagen

All Listed Sponsors
lead

Henning Bundgaard

OTHER

NCT01447654 - Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter